NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 314 / 982

  1. Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma2022 · OpenAlex
  2. Development and Evaluation of a Combined Contagious Bovine Pleuropneumonia (CBPP) and Lumpy Skin Disease (LSD) Live Vaccine2022 · Crossref
  3. Development and Optimization of an HPLC-PDA Method for the Determination of Major Cannabinoids in Hemp (Cannabis sativa L.) Essential Oil Obtained by Hydrodistillation2022 · Crossref
  4. Development and pilot-testing of a skill-based intervention to prevent psychoactive substance use among college students2022 · Crossref
  5. Development and Validation of a GC–MS-EI Method to Determine α-PHP in Blood: Application to Samples Collected during Medico-Legal Autopsies2022 · OpenAlex
  6. Development and Validation of a New Gadget Addiction Scale (Screen Dependency Scale) among Pre-School Children in Malaysia2022 · Crossref
  7. Development and Validation of a Novel and Fast Detection Method for Cannabis sativa: A 19-Plex Short Tandem Repeat Typing System2022 · Crossref
  8. Development and Validation of a Rapid Method for Identification of New Synthetic Cannabinoids in Hair Based on High-Performance Liquid Chromatography–Ion Trap Mass Spectrometry Using a Simplified User Interface2022 · OpenAlex
  9. Development and Validation of a Single Step GC/MS Method for the Determination of 41 Drugs and Drugs of Abuse in Postmortem Blood2022 · OpenAlex
  10. Development and Validation of a Uplc-Qtof-Ms Method for Blood Analysis of Isomeric Amphetamine-Related Drugs2022 · OpenAlex
  11. Development and validation of an LC-MS/MS method for the quantification of mescaline and major metabolites in human plasma2022 · OpenAlex
  12. Development and validation of ELISA for screening of Kratom (Mitragyna speciosa) habitual users using urinary AZ122 biomarker2022 · Crossref
  13. Development and Validation of Machine Models Using Natural Language Processing to Classify Substances Involved in Overdose Deaths2022 · OpenAlex
  14. Development and validation of the Dutch Social Attunement Questionnaire (SAQ)2022 · Crossref
  15. Development and Validation of the LC–MS/MS Method for Determination of 130 Natural and Synthetic Cannabinoids in Cannabis Oil2022 · OpenAlex
  16. Development and validation of the UPLC-MS method for simultaneous determination of six new psychoactive substances2022 · Crossref
  17. Development and Validation of UPLC-Qtof-MS Method for Blood Analysis of Amphetamine-Related Drug Isomers2022 · OpenAlex
  18. Development and Validation of “Divorcing the Self-Incompatible Scale” (DSIS)2022 · Crossref
  19. Development of a digital platform to improve community response to overdose and prevention among harm reduction organizations2022 · Crossref
  20. Development of a Genus-Universal Nucleotide Signature for the Identification and Supervision of Ephedra-Containing Products2022 · OpenAlex
  21. Development of a High Performance Liquid Chromatography with Diode Array Detector (HPLC-DAD) Method for Determination of Biogenic Amines in Ripened Cheeses2022 · OpenAlex
  22. Development of a Ladder-Shape Melting Temperature Isothermal Amplification (LMTIA) Assay for the Identification of Cassava Component in Sweet Potato Starch Noodles2022 · OpenAlex
  23. Development of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Simultaneous Determination of 40 Drugs of Abuse in Human Urine: Application to Real Cases2022 · OpenAlex
  24. Development of a multi-component tobacco cessation training package utilizing multiple approaches of intervention development for health care providers and patients attending non-communicable disease clinics of Punjab, India2022 · Crossref
  25. Development of a Novel Analytical Method for Determining Trazodone in Human Plasma by Liquid Chromatography Coupled With Mass Spectrometry Coupled With Automatic 2-Dimensional Liquid Chromatograph-Mass Spectrometer Coupler 9500 and Its Application to Therapeutic Drug Monitoring2022 · Crossref
  26. Development of a Problematic Khat Use Screening Test (PKUST-17) in Ethiopia: Classical Test Theory and Item Response Theory Analysis2022 · Crossref
  27. Development of Alcohol Control Policy in Vietnam: Transnational Corporate Interests at the Policy Table, Global Public Health Largely Absent2022 · Crossref
  28. Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats2022 · OpenAlex
  29. Development of an Electrochemical Sensor Using a Modified Carbon Paste Electrode with Silver Nanoparticles Capped with Saffron for Monitoring Mephedrone2022 · OpenAlex
  30. Development of an Electronic Screening and Brief Intervention to Address Perinatal Substance Use in Home Visiting: Qualitative User-Centered Approach2022 · Crossref
  31. Development of Coffee Production in Kepahiang2022 · Crossref
  32. Development of Fermented Shrimp Shell Product with Hypoglycemic and Hypolipidemic Effects on Diabetic Rats2022 · Crossref
  33. Development of Nanomaterial-Modified Impedimetric Aptasensor—A Single-Step Strategy for 3,4-Methylenedioxymethylamphetamine Detection2022 · OpenAlex
  34. Development of New Spot Test for the Identification of Ketamine and its Application for Forensic Samples - Blood, Injection, and Viscera2022 · Crossref
  35. Development of scales to measure Lebanese university students’ perceived knowledge about and attitudes about cannabis use: initial psychometric properties2022 · Crossref
  36. Development of Specialty Robusta Coffee with Saccharomyces Cerevisiae Fermentation to Improve Coffee Quality2022 · Crossref
  37. Development of the optimal composition of the nutrient medium for the cultivation of yeast in the cultivation of invertebrates2022 · Crossref
  38. Developmental trajectories of Big Five personality traits among adolescents and young adults: Differences by sex, alcohol use, and marijuana use2022 · Crossref
  39. Developmental trajectories of tobacco use and risk factors from adolescence to emerging young adulthood: a population-based panel study2022 · Crossref
  40. Developments in high-resolution mass spectrometric analyses of new psychoactive substances2022 · Crossref
  41. Deviant Peer Affiliation and Adolescent Tobacco and Alcohol Use: The Roles of Tobacco and Alcohol Information Exposure on Social Networking Sites and Digital Literacy2022 · Crossref
  42. Deviant Peer Association as a Predictor of Development of Risk for Selling Illicit Drugs: Are Effects Age-Graded?2022 · Crossref
  43. De‐prosecution and death: A synthetic control analysis of the impact of de‐prosecution on homicides2022 · Crossref
  44. Diagnostic accuracy for self‐reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine‐dependent intervention trial population2022 · OpenAlex
  45. Diagnostic capabilities of self-reported psychoactive substance use among patients admitted to psychiatric consultations in Benin, West Africa2022 · OpenAlex
  46. Dichrocephala integrifolia Aqueous Extract Antagonises Chronic and Binges Ethanol Feeding-Induced Memory Dysfunctions: Insights into Antioxidant and Anti-Inflammatory Mechanisms2022 · OpenAlex
  47. Did COVID-19-Related Alcohol Sales Restrictions Reduce Alcohol Consumption? Findings from a National Online Survey in South Africa2022 · Crossref
  48. Dietary Polyphenols and Their Role in Oxidative Stress-Induced Human Diseases: Insights Into Protective Effects, Antioxidant Potentials and Mechanism(s) of Action2022 · OpenAlex
  49. Dietary supplement mislabelling: case study on selected slimming products by developing a green isocratic HPLC method for their quality control2022 · OpenAlex
  50. Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates2022 · Crossref
  51. Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder2022 · Crossref
  52. Differences in genetic risk score profiles for drug use disorder, major depression, and ADHD as a function of sex, age at onset, recurrence, mode of ascertainment, and treatment2022 · Crossref
  53. Differences in Muscle Strength, Physical Activity, and Cardiometabolic Risk Factors between Type 2 Diabetic Patients with and Without Benzodiazepines or Antipsychotic Medications2022 · Crossref
  54. Differences in Offending Behaviors, Aggression, Substance Use, and Mental Health Problems between Male Drug Dealers and Non-Drug Dealers in Belgian Youth Detention Centers2022 · Crossref
  55. Differences in orexin-A level in the functional brain network of HUD patients undergoing harm reduction therapy2022 · Crossref
  56. Differences in personality, cognitive abilities, illicit drug use, and white matter structural integrity between hallucinogen users and matched controls2022 · OpenAlex
  57. Differences in Substance Use Disorders and Other Mental Disorders in Mental Health and Addiction Settings: Sociodemographic, Clinical, Drug Treatment, and Gender Differences2022 · Crossref
  58. Differences in the Delivery of Medications for Opioid use Disorder during Hospitalization by Racial Categories: A Retrospective Cohort Analysis;2022 · Crossref
  59. Different dimensions of wellness in drug addiction treatment2022 · Crossref
  60. Different Fertility Approaches in Organic Hemp (Cannabis sativa L.) Production Alter Floral Biomass Yield but Not CBD:THC Ratio2022 · Crossref
  61. Different Goals, Different Needs: The Effects of Telephone- and Text Message-Based Continuing Care for Patients with Different Drinking Goals After Residential Treatment for Alcohol Use Disorder2022 · Crossref
  62. Different Paths and Potentials to Harm Reduction in Different Welfare States: Drug Consumption Rooms in the United Kingdom, Denmark, and France2022 · OpenAlex
  63. Different phases of ATS use call for different interventions: a large qualitative study in Europe2022 · Crossref
  64. Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD2022 · Crossref
  65. Differential Effects of Cannabidiol and a Novel Cannabidiol Analog on Oxycodone Place Preference and Analgesia in Mice: an Opioid Abuse Deterrent with Analgesic Properties2022 · Crossref
  66. Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model2022 · OpenAlex
  67. Differential Expression of CB 1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Protein 1a in Labor2022 · Crossref
  68. Differential expression of miR‐1249‐3p and miR‐34b‐5p between vulnerable and resilient phenotypes of cocaine addiction2022 · Crossref
  69. Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review2022 · Crossref
  70. Differential price responses for tobacco consumption: implications for tax incidence2022 · Crossref
  71. Differentiating Cannabis Products: Drugs, Food, and Supplements2022 · OpenAlex
  72. Differentiating Patterns of Vaping, Alcohol, and Cannabis Use Among Early Adolescents2022 · Crossref
  73. Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada2022 · Crossref
  74. Digital Addiction and Sleep2022 · OpenAlex
  75. Digital Interventions to Save Lives From the Opioid Crisis Prior and During the SARS COVID-19 Pandemic: A Scoping Review of Australian and Canadian Experiences2022 · OpenAlex
  76. Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response2022 · Crossref
  77. Digital Treatment Paths for Substance Use Disorders (SUDs)2022 · Crossref
  78. Digital Vā: Pacific Perspectives on the Shift from ‘Ordinary Practices’ to ‘Extraordinary Spaces’ During the COVID-19 Pandemic in Aotearoa/New Zealand2022 · OpenAlex
  79. Digitalisation in the area of alcohol, drug, and tobacco during the COVID-19-pandemic: supporting the drive towards an equitable health?2022 · Crossref
  80. Dilemas sobre la participación colombiana en el mercado internacional de Cannabis2022 · Crossref
  81. Dilemmas of belonging: Young Muslim women in the Danish youth alcohol culture2022 · Crossref
  82. Diquat Poisoning: Care Management and Medico-Legal Implications2022 · OpenAlex
  83. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.2022 · PubMed
  84. Direct Deaminative Functionalization2022 · OpenAlex
  85. Direct In Vivo Analysis of CBD- and THC-Acid Cannabinoids and Classification of Cannabis Cultivars Using SpiderMass2022 · Crossref
  86. Direct multiclass desorption electrospray ionization–tandem mass spectrometry method for the analysis of sleep inducers and ototoxic drugs in dried blood spots2022 · Crossref
  87. Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries2022 · Crossref
  88. Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic2022 · Crossref
  89. Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: A discrete-time survival analysis2022 · OpenAlex
  90. Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning2022 · Crossref
  91. Discrepant Parent-Adolescent Reports of Parental Monitoring And Their Relations to Cannabis Use Among Justice-Involved Youth2022 · Crossref
  92. Diseases of Cannabis sativa Caused by Diverse Fusarium Species2022 · OpenAlex
  93. Disintegrating and Reintegrating the Self – (In)Flexible Self-Models in Depersonalisation and Psychedelic Experiences2022 · OpenAlex
  94. Disordered Eating Behaviors Related to Food Addiction/Eating Addiction in Inpatients with Obesity and the General Population: The Italian Version of the Addiction-like Eating Behaviors Scale (AEBS-IT)2022 · Crossref
  95. Disorders of cancer metabolism: The therapeutic potential of cannabinoids2022 · OpenAlex
  96. Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 20192022 · OpenAlex
  97. Disparities in Cigarette, E-cigarette, Cigar, and Smokeless Tobacco Use at the Intersection of Multiple Social Identities in the US Adult Population. Results From the Tobacco Use Supplement to the Current Population Survey 2018–2019 Survey2022 · Crossref
  98. Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic2022 · Crossref
  99. Disparities in Receipt of Medications for Opioid use Disorder among Pregnant Women2022 · Crossref
  100. Dispensação dos produtos medicamentosos derivados da Cannabis sativa L. em uma associação no município de João Pessoa-PB entre julho e dezembro de 20202022 · Crossref